Mitral valve prolapse: An atypical variation of the anatomy

Canadian Journal of Cardiology

Volumn 19, Issue 12, 2003, Pages 1367-1373

  Butany, Jagdish ^a,b   Privitera, Salvatore ^a,b   David, Tirone E ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Congenital heart disease; Mitral valve; Pathology

Indexed keywords

CERIVASTATIN; ENALAPRIL; FLECAINIDE; FUROSEMIDE; GLYCOSAMINOGLYCAN; LEVOTHYROXINE; METOPROLOL; PAROXETINE; POTASSIUM CHLORIDE; RAMIPRIL; SIMVASTATIN; TELMISARTAN;

ADULT; AGED; ARTICLE; AUTOPSY; CHORDA TENDINEA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEART PAPILLARY MUSCLE; HEART VALVE SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MITRAL VALVE PROLAPSE; MORPHOLOGY; PATHOLOGICAL ANATOMY;

ADULT; AGED; CHORDAE TENDINEAE; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE PROLAPSE; PAPILLARY MUSCLES;

EID: 0346816534     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ranganathan N, Lam JHC, Wigle ED, Silver MD. Morphology of the human mitral valve II: The valve leaflets. Circulation 1970;41:459-67.
2. Lam JHC, Ranganathan N, Wigle ED, Silver MD. Morphology of the human mitral valve I: Chordae tendinae: A new classification. Circulation 1970;41:449-57.
3. Becker AE, De Wit APM. Mitral valve apparatus: A spectrum of normality relevant to mitral valve prolapse. Br Heart J 1979;42:680-9.
4. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341:1-7.
5. Tamura K, Fukuda Y, Ishizaki M, Masuda Y, Yamanaka N, Ferrens VJ. Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am Heart J 1995;129:1149-58.
6. Devereux RB, Brown WT, Kramer-Fox R, Sachs I. Inheritance of mitral valve prolapse: Effect of age and sex on gene expression. Ann Intern Med 1982;97:826-32.
7. Savage DD, Garrison RJ, Devereux RB, et al. Mitral valve prolapse in the general population. I. Epidemiologic features: The Framingham Study. Am Heart J 1983; 106:571-6.
8. Lucas RV Jr, Edwards JE. The floppy mitral valve. Curr Probl Cardiol 1982;7:1.
9. Leier CV, Call TD, Fulkerson PK, Wooley CF. The spectrum of cardiac defects in the Ehlers-Danlos syndrome, types I and III. Ann Intern Med 1980;92:171-8.
10. Lebwohl MG, Distefano D, Prioleau PG, Uram M, Yannuzzi LA, Fleischmajer R. Pseudoxanthoma elasticum and mitral-valve prolapse. N Engl J Med 1982;307:228-31.
11. Crawford MH. Mitral valve prolapse due to coronary artery disease. Am J Med 1977;62:447-51.
12. Tei C, Sakamaki T, Shah PM, et al. Mitral valve prolapse in short-term experimental coronary occlusion: A possible mechanism of ischemic mitral regurgitation. Circulation 1983;68:183-9.
13. Tomaru T, Uchida Y, Mohri N, Mori W, Furuse A, Asano K. Postinflammatory mitral and aortic valve prolapse: A clinical and pathological study. Circulation 1987;76:68-76.
14. Lembo NJ, Dell'italia LJ, Crawford MH, Miller HF, Richards KL, O'Rourke RA. Mitral valve prolapse inpatients with prior rheumatic fever. Circulation 1988;77:830-6.
15. Crawford MH, O'Rourke RA. Mitral valve prolapse: A cardiomyopathic state? Prog Cardiovasc Dis 1984;27:133-9.
16. Channick BJ, Adlin EV, Marks AD, et al. Hyperthyroidism and mitral-valve prolapse. N Engl J Med 1981;305:497-500.
17. Brauman A, Rosenberg T, Gilboa Y, Algom M, Fuchs L, Schlesinger Z. Prevalence of mitral valve prolapse in chronic lymphocytic thyroiditis and nongoitrous hypothyroidism. Cardiology 1988;75:269-73.
18. Connonly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997;337:581-8.
19. Khan MA, Herzog CA, St Peter JV, et al. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Engl J Med 1998;329:713-8.
20. Weissman NJ, Tighe JF, Gottdiener JS, Gwynne JT. Prevalence of valvular-regurgitation associated with dexfenfluramine three to five months after discontinuation of treatment. J Am Coll Cardiol 1999;34:2088-95.
21. Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease: Clinical and echocardiographic spectrum in 74 patients. Circulation 1993;87:1188-96.
22. Materazzo C, Meazza R, Stefanelli M, Biasi S. Left valvular involvement in carcinoid: Description of a case. G Ital Cardiol 1994;24:429-33.
23. Mason JW, Billingham ME, Friedman JP. Methysergide-induced heart disease: A case of multivalvular and myocardial fibrosis. Circulation 1977;56:889-90.
24. Flaherty KR, Bates JR. Mitral regurgitation caused by chronic ergotamine use. Am Heart J 1996;131:603-6.
25. Johnson LD, Caulfield JB. Morphology of myxomatous valves. Int J Cardiol 1983;3:373-7.
26. Baker PB, Bansal G, Boudoulas H, Kolibash AJ, Kilman J, Wooley CF. Floppy mitral valve chordae tendinae: Histopathologic alterations. Hum Pathol 1988;19:507-12.
27. Olsen EGJ, Al-Rufaie HK. The floppy mitral valve: Study on pathogenesis. Br Heart J 1980;44:674-83.